CropLife America Testifies Before House Ag Committee on Importance of PRIA Reauthorization
WASHINGTON, DC – On Tuesday, Beau Greenwood, executive vice president of government relations and public affairs at CropLife America (CLA), testified before the Agriculture Committee of the U.S. House of Representatives at a roundtable session on the reauthorization of the industry’s fee-for-service program, commonly referred to as the Pesticide Registration Improvement Act (PRIA). The current authority for PRIA will expire on September 30, 2017. In his testimony, Greenwood noted the diverse support for the program, including industry, users of pesticides, state and federal regulators, and the NGO community. An overview of the benefits of this program, as developed by the PRIA coalition, is available online.
Greenwood notes that, “The PRIA fee framework ensures that pesticide products will be available to support American agriculture; make available the disinfectants used by facilities managers; provide the tools necessary to combat mosquito and other vector control in the public health sector; ensure the availability of structural pesticides for residential and commercial purposes; and [support the] home & garden and turf & ornamental industries as well as golf course managers. Consequently, those pesticide uses that most of us take for granted in our daily lives remain available and therefore, we are all beneficiaries of this necessary and important fee-for-service program that funds, in part, [the U.S. Environmental Protection Agency’s] pesticide registration and review programs.”
He adds, “the support enjoyed by this program reflects the commitment and sincere efforts of all stakeholders who work at the intersection of pesticide and public policy. Our primary underlying statute, [the Federal Insecticide, Rodenticide, and Fungicide Act], allows for the simultaneous protection of human health and the environment and for a predictable registration process. The process improvements and business certainty created by PRIA are an invaluable piece of this regulatory puzzle.”